We are excited to announce that Xenon has raised €1m in funding for our hands-free, infrared temperature testing device, Fever Defence. This investment was made by a New York venture partnership and will help us scale our operations across Europe and the US.
Fever Defence uses thermal imaging and a facial detection camera to test people’s temperatures when they enter a building or work site. It can measure skin temperature in less than a second and is accurate up to plus or minus 0.3 degrees Celsius. If a potential fever-level temperature is detected, Fever Defence alerts the individual with a red and green light stop-go system and an audible notification.
Our devices have already been installed by companies and organisations across a variety of industries, including construction sites, offices, retail, and childcare settings, in Ireland, the US, and Europe. Fever Defence acts as the first layer of defence for businesses as they navigate operating during the pandemic. This funding will allow us to expand our reach and help organisations across the globe reopen for business as soon and as safely as possible.
Paddy Byrne, Managing Director of Xenon Fever Defence, commented: “We are delighted to have secured this investment, which will help us scale our operations across Europe and the US. Employers are moving quickly to put additional safety measures in place to protect their workplaces and their customers against the risk of Covid-19.”
Antonio Ruiz-Giménez, representing the investment partnership, added: “The product has excellent market potential and we are looking forward to working with the team to help them advance and scale in Ireland, Europe, the US and beyond.”
We are proud to be one of many companies currently focusing on solutions to problems posed by the coronavirus pandemic. Thank you to our investment partners for their support and trust in our company. We look forward to continuing to help businesses reopen safely.